Immune–Metabolic Dysfunction in MASLD: Biomarkers and Therapeutic Modulation

  • 506

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 12 May 2026

  2. This Research Topic is currently accepting articles.

Background

Metabolic dysfunction–associated steatotic liver disease (MASLD) emerges from a tightly interwoven network of immune and metabolic disturbances that drive steatosis, inflammation, fibrosis progression, and extrahepatic complications. This project delineates the bidirectional crosstalk between hepatocyte lipid handling, mitochondrial stress, and innate/adaptive immune activation—focusing on pathways such as lipotoxicity, oxidative stress, inflammasome signaling (e.g., NLRP3), gut–liver axis perturbations, and cytokine/chemokine networks that perpetuate hepatic injury.



We aim to:



Identify and validate multimodal biomarkers that capture immune–metabolic activity across the MASLD spectrum, integrating serum proteins (e.g., keratin-18, cytokines), lipidomic and metabolomic signatures, cell-free nucleic acids, and microbiome-derived metabolites with imaging (e.g., MRI-PDFF, elastography) and machine-learning–based composite scores.

Map patient endotypes using systems biology to improve risk stratification and predict therapeutic response.

Evaluate therapeutic strategies that modulate immune–metabolic circuits, including lifestyle and dietary interventions, GLP-1/GIP receptor agonists, FGF21 analogs, PPAR and THR-β agonists, SGLT2 inhibitors, and anti-inflammatory/anti-fibrotic approaches (e.g., CCR2/CCR5 blockade, inflammasome inhibitors), as well as combination regimens.

By integrating deep phenotyping with mechanistic insights, this research seeks to establish actionable biomarkers and targeted interventions that personalize care, prevent progression to steatohepatitis and advanced fibrosis, and reduce cardiometabolic risk in MASLD.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Classification
  • Clinical Trial
  • Community Case Study
  • Data Report
  • Editorial
  • FAIR² Data
  • FAIR² DATA Direct Submission

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: MASLD biomarkers; Immune–metabolic crosstalk; NLRP3 inflammasome; Endotypes and stratification; Anti-fibrotic therapeutics

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 506Topic views
View impact